In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery
{{output}}
Ex vivo autologous haematopoietic stem cell (HSC) gene therapy provides a promising treatment option for haematological disorders. However, current methods involve complex processes and chemotherapeutic conditioning, leading to limited accessibility for treatm... ...
